Novozymes’ technology platform provides a wealth of opportunities for the world’s industries and ensures Novozymes a good foundation for future growth inside and outside the enzymes area.
Novozymes’ current market situation and product portfolio is strong and the future looks promising for our long-term value creation. This is because Novozymes’ technology platform offers sustainable solutions that are well suited to the challenges of global development – such as the need to improve the balance between social, environmental and economic factors.
Three global trends are focusing attention on Novozymes’ products and research:
The threat of climate change with major consequences for the environment, society and humanity as a whole calls for joint efforts and responsibility.
For Novozymes, it is altogether about responsibility, risk management and business opportunities. Our ambition is to help limit global warming as much as possible, mainly by exploiting the opportunities available in our modern biotechnology. Enzyme technology for industrial processes has a wealth of unexplored potential for limiting emissions of greenhouse gases.
But Novozymes is also an energy consumer. For many years we have successfully set and achieved goals for energy efficiency in our own production, and over the past 10 years we have increased our efficiency by more than 50%. Energy savings and the rationalization of Novozymes’ own production will always be high on our agenda. Our goal is to continue ensuring that business growth and the emission of greenhouse gases do not follow hand in hand.
Novozymes’ climate strategy
The scope of Novozymes’ climate strategy is wide-ranging, as the products’ entire life cycle is in focus:
The strategy encourages a joint effort and partnerships with customers and suppliers, as this is the key to unlocking the great potential for limiting the emission of greenhouse gases.
Strong technology ‘tool box’
Gene technology, microbial techniques and fermentation techno-logy are some of the biotechnological tools on which Novozymes bases its business. This platform enables Novozymes to offer a wide range of different solutions to industries worldwide.
The enzyme business currently comprises more than 90% of Novozymes’ sales and, in the future, will also make up the most important part of Novozymes’ business. But in recent years, this technology platform has also enabled us to expand our business outside the enzyme area. We have now united these activities into one organizational unit, BioBusiness, to provide the necessary focus on growth. The new activities open doors to new and exciting markets for Novozymes and help us to develop and diversify our long-term business.